{"gene":"PITX1","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":1996,"finding":"PITX1 (Ptx1) is a bicoid-related homeodomain transcription factor that activates transcription of the POMC gene by binding sequences related to Drosophila bicoid target sites in a pituitary-cell-specific manner.","method":"Transcription factor cloning from AtT-20 cells, DNA-binding assays, reporter gene assays, in situ hybridization","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 — original cloning with DNA-binding and transactivation assays, foundational paper with >300 citations","pmids":["8675014"],"is_preprint":false},{"year":1996,"finding":"PITX1 (P-OTX) physically interacts with the transactivation domain of the pituitary-specific POU domain protein Pit-1, and synergizes with Pit-1 to activate pituitary-specific target gene promoters.","method":"Interaction-based cloning, co-activation reporter assays in pituitary cell lines","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction identified by protein-interaction screen and functional synergy assays, >200 citations","pmids":["8755540"],"is_preprint":false},{"year":1998,"finding":"PITX1 acts as a pan-pituitary transcriptional activator that synergizes with SF-1 on the LHβ promoter and with Pit1 on the PRL promoter; antisense depletion shows the downstream Lim3/Lhx3 gene is highly dependent on PITX1, placing PITX1 upstream of Lhx3 in a pituitary transcriptional cascade.","method":"Reporter gene assays, antisense RNA knockdown in αT3-1 cells, co-transfection synergy assays","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — epistasis established by antisense knockdown with defined target-gene readout, replicated across multiple promoters, >240 citations","pmids":["9514159"],"is_preprint":false},{"year":1999,"finding":"Pitx1 gene deletion in mice causes severe hindlimb morphogenesis defects (absent ilium, underdeveloped long bones, loss of knee cartilage) with decreased Tbx4 expression in the hindlimb, demonstrating Pitx1 is required upstream of Tbx4 for hindlimb identity and chondrogenesis.","method":"Targeted gene knockout in mice, in situ hybridization, skeletal analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined morphological and molecular phenotype, independently corroborated by Szeto et al. 1999, >230 citations","pmids":["10101115"],"is_preprint":false},{"year":1999,"finding":"Pitx1 gene deletion causes striking hindlimb abnormalities (tibia/fibula and patella defects resembling forelimb) with decreased distal Tbx4 expression; misexpression of Pitx1 in chick wing bud induces Tbx4 and causes hindlimb-like digit morphology, establishing Pitx1 as a hindlimb identity determinant acting through Tbx4.","method":"Mouse knockout, chick limb misexpression (retroviral), skeletal morphology analysis, in situ hybridization","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 — loss-of-function and gain-of-function in two species with defined molecular target, >340 citations","pmids":["10049363"],"is_preprint":false},{"year":1999,"finding":"Misexpression of Pitx1 in the chick wing bud induces distal expression of Tbx4, HoxC10, and HoxC11, and transforms wing morphology toward hindlimb characteristics, placing Pitx1 upstream of Tbx4 in the hindlimb identity pathway.","method":"Retroviral misexpression in chick wing bud, in situ hybridization, morphological analysis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function with defined molecular targets, independently replicated, >230 citations","pmids":["10073939"],"is_preprint":false},{"year":1999,"finding":"PITX1 C-terminus directly interacts with the N-terminal half of SF-1; this physical interaction enhances SF-1 transcriptional activity on LHβ and MIS promoters to a level equivalent to a constitutively active SF-1 mutant, mimicking the effect of an SF-1 ligand.","method":"Mammalian two-hybrid assay, reporter gene assays, domain-mapping mutagenesis, co-transfection","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — direct protein–protein interaction mapped with mutagenesis and functional consequence defined, >100 citations","pmids":["10369682"],"is_preprint":false},{"year":1999,"finding":"GnRH induces Egr-1 expression (but not Pitx1 or SF-1); Egr-1 then directly interacts with Pitx1 and SF-1, enhancing Pitx1- and SF-1-induced LHβ transcription, establishing Egr-1 as a GnRH-responsive transcriptional mediator that functions through physical interaction with PITX1.","method":"Reporter gene assays, PKC activation, direct protein interaction assays (co-immunoprecipitation/pull-down implied), synergy assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — direct physical interaction plus functional synergy with signal-pathway epistasis, >225 citations","pmids":["10082522"],"is_preprint":false},{"year":1999,"finding":"PITX1 is expressed in all pituitary cell types but at differentially quantitative levels; highest expression correlates with α-glycoprotein subunit-expressing cells throughout pituitary development, as shown by co-immunolocalization.","method":"Immunohistochemistry, co-immunolocalization, differential mRNA/protein quantification","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 3 — localization with functional implication but no direct functional manipulation","pmids":["10067870"],"is_preprint":false},{"year":2000,"finding":"FGF8 can induce/maintain Pitx1 and Pitx2 expression in the developing mandible, while BMP4 represses Pitx1 expression in mandibular mesenchyme, as shown by bead implantation experiments establishing antagonistic FGF8/BMP4 regulation of Pitx1.","method":"Bead implantation experiments in mouse embryos, in situ hybridization","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo gain/loss of signaling with defined Pitx1 expression readout","pmids":["10625557"],"is_preprint":false},{"year":2000,"finding":"Pitx1 represses virus-induced IFN-A promoters by binding to the distal negative regulatory element (DNRE); the C-terminal region and homeodomain of Pitx1 are required for repression; antisense Pitx1 increases endogenous IFN-A transcription.","method":"Yeast one-hybrid (DNRE-binding protein identification), reporter assays, antisense RNA, EMSA, domain-mapping mutagenesis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — DNA binding demonstrated, functional domains mapped, antisense loss-of-function confirms endogenous role","pmids":["11003649"],"is_preprint":false},{"year":2001,"finding":"A single Pitx1 binding site in the LHβ promoter is absolutely required for promoter activity in transgenic mice; mutation of this element abolishes both basal activity and GnRH responsiveness, demonstrating that cooperative interactions between Pitx1, SF-1, and Egr-1 depend on Pitx1 DNA binding in vivo.","method":"Transgenic mouse reporter assays, transient transfection in LβT2 gonadotrope-derived cells, site-directed mutagenesis","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo transgenic validation with mutagenesis, defining essential cis-regulatory requirement","pmids":["11328855"],"is_preprint":false},{"year":2002,"finding":"PITX1 physically interacts with IRF3 and IRF7 via its homeodomain; specific C-terminal domains of Pitx1 mediate trans-repression of IFN-A11 and IFN-A5 (but not IFN-A4) promoter activities, and this repression is not mediated by histone deacetylase recruitment.","method":"Co-immunoprecipitation, domain-mapping mutagenesis, reporter gene assays, EMSA","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — direct physical interaction with functional domain mapping, mechanism of repression distinguished from HDAC pathway","pmids":["12242290"],"is_preprint":false},{"year":2002,"finding":"Pitx1 can homodimerize, phosphorylates on three residues when DNA-bound, and acts through multiple mechanisms on the LHβ promoter including synergy with SF-1 and estrogen receptor, binding to four upstream Pitx1 response elements, and inducing conformational changes in the DNA as shown by circular permutation assay.","method":"Mammalian two-hybrid (homodimerization), circular permutation assay (DNA bending), phosphorylation analysis, reporter gene assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple mechanisms demonstrated in a single study but limited independent replication","pmids":["12011080"],"is_preprint":false},{"year":2003,"finding":"PITX1 positively autoregulates its own promoter in a DNA-binding- and transactivation-domain-dependent manner; Pitx1, Pitx1b, Pitx2, and Otx1 all activate the PITX1 promoter in transfection assays, while transgenic mouse studies show that PITX1 promoter fragments reproduce anterior (but not posterior) expression.","method":"Transgenic mouse reporter assays, transient transfection, domain-mapping mutagenesis","journal":"Neuroendocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — functional promoter characterization with domain mapping in transgenic mice","pmids":["14512705"],"is_preprint":false},{"year":2003,"finding":"HCV NS5A protein physically interacts with human PITX1 (hPTX1) as identified by yeast two-hybrid and confirmed by mammalian two-hybrid, co-immunoprecipitation, and colocalization; co-expression of NS5A and hPTX1 reduces IFN-α promoter activity compared to either alone.","method":"Yeast two-hybrid, mammalian two-hybrid, co-immunoprecipitation, colocalization, reporter assays","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods confirming interaction, but single lab study","pmids":["12620797"],"is_preprint":false},{"year":2005,"finding":"PITX1 suppresses RAS pathway activity and tumorigenicity by transcriptionally activating RASAL1, a RAS-GTPase-activating protein; knockdown of PITX1 activates RAS signaling and transforms human primary cells, while restoration of PITX1 in colon cancer cells inhibits tumorigenicity in a wild-type RAS-dependent manner.","method":"RNAi library screen, reporter assays, soft-agar transformation assay, expression analysis, epistasis (RAS-dependence test)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with defined molecular target (RASAL1), functional rescue assays, >237 citations","pmids":["15960973"],"is_preprint":false},{"year":2007,"finding":"DUX4 protein directly binds a 30-bp sequence in the PITX1 promoter (TAAT core required) and transcriptionally activates both a PITX1 luciferase reporter and the endogenous PITX1 gene in C2C12 cells.","method":"Luciferase reporter assays, EMSA, site-directed mutagenesis of TAAT core, qRT-PCR of endogenous PITX1","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — direct DNA binding by EMSA with mutagenesis plus endogenous gene activation confirmed","pmids":["17984056"],"is_preprint":false},{"year":2007,"finding":"PITX1 directly activates transcription of the p53 gene by binding to two PITX1 consensus elements in the p53 promoter, including one within the first exon; forced PITX1 expression causes p53-dependent cell-cycle arrest and apoptosis in MCF-7 cells, and PITX1 siRNA reduces basal p53 expression.","method":"Luciferase reporter assays, ChIP, site-directed mutagenesis, siRNA knockdown, apoptosis assays, dominant-negative PITX1","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding by ChIP + mutagenesis + loss-of-function with defined p53-dependent phenotype","pmids":["17762884"],"is_preprint":false},{"year":2007,"finding":"Bone morphogenetic protein-4 (BMP4) down-regulates Pitx1 expression in both mandibular mesenchyme and dental epithelium, as shown by tissue recombination and bead implantation experiments; Pitx1 deletion results in decreased Barx1 expression in molar mesenchyme and suppression of Tbx1 in dental epithelium.","method":"Tissue recombination, bead implantation, in situ hybridization, Pitx1-/- mouse analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo signaling manipulation plus KO phenotype with molecular readouts","pmids":["18082678"],"is_preprint":false},{"year":2008,"finding":"A missense mutation in the PITX1 homeodomain (E130K) reduces PITX1 transactivation activity in luciferase reporter assays and suppresses wild-type PITX1 activity in a dose-dependent manner, indicating dominant-negative effects; this mutation segregates with autosomal dominant lower-limb malformations including clubfoot.","method":"Luciferase reporter assay, dominant-negative suppression assay, linkage analysis","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — defined molecular mechanism (dominant-negative) demonstrated functionally in human disease mutation","pmids":["18950742"],"is_preprint":false},{"year":2009,"finding":"Pelvic loss in threespine sticklebacks evolves repeatedly through regulatory mutations deleting a tissue-specific pelvic enhancer of Pitx1 (PelA), reducing Pitx1 expression selectively in pelvic tissue without affecting the rest of Pitx1 expression; this represents an enhancer-based mechanism for morphological evolution.","method":"Population genetics, enhancer deletion analysis, expression studies, sequence analysis for selection signatures","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — natural deletion of a defined enhancer with expression and morphological phenotype, >739 citations","pmids":["20007865"],"is_preprint":false},{"year":2011,"finding":"PITX1 suppresses hTERT transcription by directly binding to conserved binding sites in the hTERT promoter (three sites in hTERT, one in mouse Tert), as shown by in vitro and in vivo (ChIP) binding assays, ultimately reducing telomerase activity.","method":"Microcell-mediated chromosome transfer, cDNA microarray, luciferase reporter assays, EMSA (in vitro binding), ChIP (in vivo binding)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — direct promoter binding by both EMSA and ChIP, functional suppression of telomerase activity demonstrated","pmids":["21300782"],"is_preprint":false},{"year":2011,"finding":"Pitx1 haploinsufficiency causes clubfoot in mice with 8.9% penetrance; the affected hindlimb shows peroneal artery hypoplasia and reduced lateral muscle compartments; skeletal muscle gene expression is significantly reduced in Pitx1-/- E12.5 hindlimb buds, indicating early muscle developmental defects.","method":"Pitx1 heterozygous mouse breeding, copy number analysis in human patients, MRI, skeletal phenotyping, gene expression analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — haploinsufficiency model with quantitative molecular and morphological phenotype, human genetic validation","pmids":["21775501"],"is_preprint":false},{"year":2011,"finding":"PITX1 expression is robustly induced by estradiol (E2) in ERα-positive breast cancer cells via ERα-dependent interaction between the PITX1 proximal promoter and an upstream enhancer; PITX1 selectively inhibits ERα and ERβ transcriptional activity while enhancing glucocorticoid and progesterone receptor activities, and PITX1 is co-recruited with ERα to ERα binding sites.","method":"ChIP, reporter assays, siRNA knockdown, genome-wide ERα binding site analysis","journal":"Molecular endocrinology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — ChIP-confirmed direct recruitment, functional siRNA knockdown showing ERα target gene regulation","pmids":["21868451"],"is_preprint":false},{"year":2011,"finding":"Pitx1 is necessary for normal hindlimb outgrowth by regulating Tbx4 expression levels; a transgenic gene replacement strategy uncouples two discrete functions: (1) influencing hindlimb outgrowth through Tbx4 regulation, and (2) shaping hindlimb bone/soft tissue morphology independently of Tbx4, via localized modulation of growth rate of skeletal elements.","method":"Transgenic Pitx1 rescue in Pitx1-/- background, skeletal morphometry, molecular expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genetic dissection of two functional outputs using transgenic rescue, clean epistasis","pmids":["22071103"],"is_preprint":false},{"year":2012,"finding":"Genome-wide ChIP-Seq in mouse hindlimbs shows Pitx1 binding is significantly enriched near limb morphogenesis genes including Tbx4, HoxC10, and HoxC11; Pitx1 is directly bound to the HLEA and HLEB hindlimb enhancers of Tbx4 and a Tbx2 hindlimb enhancer; Pitx1 binding is significantly enriched on hindlimb-specific vs. forelimb-specific cis-regulatory elements.","method":"ChIP-Seq, H3K27ac chromatin marking, genome-wide analysis of limb enhancers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 — genome-wide direct binding data with enhancer-level resolution confirming Tbx4 as a direct target","pmids":["23201014"],"is_preprint":false},{"year":2012,"finding":"Conditional muscle-specific overexpression of PITX1 in mice causes skeletal muscle dystrophy (weight loss, muscle mass reduction, atrophic fibers, necrosis, inflammation) with upregulation of p53 in affected muscles, suggesting PITX1 drives atrophy through p53-dependent pathways.","method":"Tet-repressible transgenic mouse model, histopathology, immunoblotting, immunohistochemistry, grip strength testing","journal":"Biology open","confidence":"High","confidence_rationale":"Tier 2 — inducible transgenic overexpression with defined phenotype and molecular mechanism (p53 pathway)","pmids":["23125914"],"is_preprint":false},{"year":2013,"finding":"The RNA helicase RHAU (DHX36) binds the PITX1 mRNA via a non-quadruplex-forming region and suppresses PITX1 protein expression post-transcriptionally through microRNA machinery (requiring Dicer and Argonaute-2) without substantially affecting mRNA levels.","method":"RNA co-immunoprecipitation, siRNA knockdown of RHAU/Dicer/Ago2, Western blotting, RNA G-quadruplex characterization","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal knockdown experiments defining the RHAU-miRNA-Ago2 regulatory mechanism on PITX1 translation","pmids":["24369427"],"is_preprint":false},{"year":2014,"finding":"PITX1 associates with HIF-1β and is required for HIF-1α-dependent induction of specific histone demethylases (JMJD2B, JMJD2A, JMJD2C, JMJD1B) but not all HIF-1 target genes; PITX1-depleted cells show increased apoptosis and reduced proliferation under hypoxia.","method":"Co-immunoprecipitation (PITX1-HIF-1β interaction), siRNA knockdown, gene expression analysis, apoptosis/proliferation assays","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 — direct interaction plus loss-of-function with defined transcriptional and cellular phenotypes, single lab","pmids":["25558831"],"is_preprint":false},{"year":2015,"finding":"miR-19b directly inhibits PITX1 mRNA translation through a binding site in the 3'UTR of PITX1 mRNA, leading to increased hTERT expression; overexpression of miR-19b reduces PITX1 protein without substantially affecting mRNA, establishing miR-19b as an upstream regulator of the PITX1-hTERT suppressor axis.","method":"miR-19b overexpression, 3'UTR luciferase reporter assays, Western blotting, qRT-PCR","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — direct 3'UTR target validation with functional downstream consequences, single lab","pmids":["25643913"],"is_preprint":false},{"year":2016,"finding":"PTP1B directly dephosphorylates PITX1 at Y160, Y175, and Y179, destabilizing PITX1 protein; PTP1B-dependent reduction in PITX1 decreases its transcriptional activity on the p120RasGAP (RASA1) promoter; PTP1B inhibition or sorafenib treatment hyperphosphorylates PITX1 and upregulates the PITX1-p120RasGAP axis.","method":"FLAG pull-down, phosphorylation site mapping, PTP1B inhibition, PTP1B silencing, reporter assays, molecular docking, in vivo xenograft","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 1-2 — direct enzymatic dephosphorylation with specific phosphorylation sites identified, functional consequences on PITX1 stability and transcriptional activity, in vitro and in vivo validation","pmids":["26840794"],"is_preprint":false},{"year":2016,"finding":"E2F1, in complex with its dimerization partner TFDP1, directly activates PITX1 transcription by binding to two specific sequences in the PITX1 proximal promoter, as confirmed by ChIP and DNA pulldown; TFDP1 knockdown reduces both PITX1 promoter activity and mRNA levels in articular chondrocytes.","method":"Luciferase reporter assays, ChIP, DNA pulldown, siRNA knockdown (TFDP1)","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding confirmed by ChIP and DNA pulldown with functional promoter assays","pmids":["27802335"],"is_preprint":false},{"year":2017,"finding":"ChIP-Seq and RNA-Seq in Pitx1-/- mouse hindlimbs identify 440 candidate direct PITX1 targets; 68 are ultra-conserved between mouse and Anolis lizard hindlimbs, including Sox9 and Six1, indicating PITX1 directly promotes chondrogenesis and myogenesis by activating key members of cartilage and muscle transcriptional networks.","method":"ChIP-Seq, RNA-Seq in Pitx1-/- embryos, cross-species (mouse/Anolis) comparison","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 — genome-wide direct binding combined with KO transcriptomics, cross-species conservation supports functional relevance","pmids":["29273440"],"is_preprint":false},{"year":2017,"finding":"Expression profiling and direct Pitx1 target analysis show Pitx1 acts on sites in a similar chromatin state in both forelimb and hindlimb, controlling both patterning genes and the chondrogenic program, consistent with impaired chondrogenesis in Pitx1-/- hindlimbs; Pitx1 operates within a narrow network of hindlimb-restricted regulators to redirect the generic limb program.","method":"RNA-Seq, ChIP-Seq, H3K27ac chromatin profiling in FL/HL, Pitx1-/- analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 — genome-wide direct target identification with chromatin state analysis and KO validation","pmids":["28807899"],"is_preprint":false},{"year":2018,"finding":"A newly identified pelvic enhancer (PelB) downstream of Pitx1 drives expression in the posterior hindlimb; PelB deletion in mice reduces hindlimb structure size; a wild stickleback population lacking the pelvis has an insertion/deletion disrupting PelB, showing this ancient enhancer contributes to evolutionary pelvic appendage modification.","method":"Transgenic enhancer reporter assay, CRISPR deletion in mice, skeletal phenotyping, stickleback population genetics","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — enhancer deletion in mouse with defined morphological phenotype plus natural variant validation","pmids":["30499775"],"is_preprint":false},{"year":2019,"finding":"PITX1 cooperates with SOX2 and TRP63 in squamous cell carcinoma tumor propagating cells to sustain a transcriptional feed-forward circuit that maintains self-renewal while repressing KLF4-dependent differentiation; PITX1 knockdown inhibits self-renewal and KLF4 overexpression represses PITX1/SOX2/TRP63 expression, forming a bistable network.","method":"Gene targeting (CRISPR), ChIP-Seq, RNA-Seq, functional self-renewal assays in mouse and human SCC","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-Seq, KO, and transcriptomic analysis with functional cellular assays defining circuit architecture","pmids":["30713093"],"is_preprint":false},{"year":2019,"finding":"PITX1 interacts with ZCCHC10 via its homeodomain; co-expression of PITX1 and ZCCHC10 cooperatively suppresses hTERT transcription in melanoma cells; homeodomain-deleted PITX1 cannot interact with ZCCHC10 and does not suppress hTERT, identifying PITX1-ZCCHC10 as a functional transcriptional repressor complex.","method":"FLAG pull-down assay, co-expression functional assays, deletion mutagenesis of homeodomain, qRT-PCR","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — direct interaction confirmed by pull-down with domain-mapping, functional outcome measured, single lab","pmids":["31404068"],"is_preprint":false},{"year":2019,"finding":"H2AFY promoter deletion causes ectopic Pitx1 expression in forelimbs (Liebenberg syndrome) because the H2AFY promoter insulates the Pen hindlimb enhancer from Pitx1 in forelimbs; loss of this insulation allows the pan-limb active Pen enhancer to drive Pitx1 in forelimbs, demonstrated by CRISPR-Cas9 re-engineering of the human deletion in mouse.","method":"Whole genome sequencing (human patients), CRISPR-Cas9 engineering in mouse, expression analysis","journal":"Journal of medical genetics","confidence":"High","confidence_rationale":"Tier 2 — precise in vivo genome editing recapitulating the human deletion with mechanistic explanation of enhancer insulation","pmids":["30711920"],"is_preprint":false},{"year":2020,"finding":"PITX1 drives astrocyte differentiation from human embryonic stem cells by directly activating the SOX9 promoter through a unique binding motif; PITX1 overexpression accelerates astrocyte differentiation and increases SOX9 expression, while PITX1 knockdown blocks differentiation and reduces SOX9.","method":"Luciferase reporter assays, EMSA, ChIP, siRNA knockdown, overexpression, human ESC differentiation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct SOX9 promoter binding by EMSA and ChIP, loss- and gain-of-function with defined cellular differentiation phenotype","pmids":["32759168"],"is_preprint":false},{"year":2021,"finding":"Deletion of the Pen enhancer disrupts the Pitx1 regulatory landscape: single-cell transcriptomics and in-embryo cell tracing show increased fraction of Pitx1 non/low-expressing cells and loss of Pitx1 high-expressing cells, due to failure to coordinate enhancer activities and 3D chromatin changes, leading to a localized heterochrony, loss of irregular connective tissue, and a clubfoot phenotype.","method":"Pen enhancer deletion, single-cell RNA-Seq, in-embryo cell tracing, 3D chromatin analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — precise enhancer deletion with single-cell resolution phenotyping revealing regulatory landscape coordination mechanism","pmids":["34903763"],"is_preprint":false},{"year":2022,"finding":"PITX1 interacts with STAT3 transcription factor, leading to decreased STAT3 transcriptional activity, which represses LINC00662 expression; PITX1 knockdown increases LINC00662, which is packaged into exosomes and activates M2 macrophage polarization, promoting osteosarcoma metastasis via CCL22.","method":"Ubiquitination assays, rescue experiments, co-immunoprecipitation implied, cell co-culture, exosome isolation assays","journal":"Clinical & experimental metastasis","confidence":"Medium","confidence_rationale":"Tier 3 — interaction with STAT3 shown with functional rescue but interaction method not fully described as reciprocal Co-IP","pmids":["36334221"],"is_preprint":false},{"year":2010,"finding":"SEDLIN interacts with PITX1 in the nucleus; SEDT-associated SEDLIN mutations (Ser73Leu, Phe83Ser, Val130Asp, Gln131Stop, but not Asp47Tyr) abolish interaction with PITX1 in yeast assays (where homodimerization masking is absent); wild-type SEDLIN localizes to both cytoplasm and nucleus.","method":"Yeast two-hybrid, COS7 cell co-expression, subcellular localization, 3D structural modeling","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — interaction confirmed in yeast null system with mutation mapping, but mammalian pulldown confounded by homodimerization","pmids":["20498720"],"is_preprint":false}],"current_model":"PITX1 is a bicoid-related homeodomain transcription factor that functions as both a transcriptional activator and repressor: it activates hindlimb identity genes (most critically Tbx4, as well as Sox9, Six1, HoxC10/C11), POMC, LHβ and other pituitary hormone genes, p53, hTERT-suppressing circuits, and SOX9 during astrocyte differentiation, while repressing IFN-A promoters (through physical interaction with IRF3/IRF7), ERα activity, and hTERT transcription (in complex with ZCCHC10); its activity is modulated by direct protein interactions with SF-1, Pit-1, Egr-1, HIF-1β, SEDLIN, and HCV NS5A, by post-translational dephosphorylation at Y160/Y175/Y179 by PTP1B (which destabilizes PITX1), by transcriptional regulation via E2F1/TFDP1 and DUX4, and by post-transcriptional suppression through RHAU helicase and miR-19b acting on 3'UTR G-quadruplexes; in development, Pitx1 expression in the hindlimb mesenchyme is controlled by tissue-specific enhancers (PelA, PelB, Pen) whose deletion causes pelvic/hindlimb reduction, and Pitx1 haploinsufficiency causes clubfoot by disrupting a lateral lower-leg developmental field."},"narrative":{"teleology":[{"year":1996,"claim":"Identification of PITX1 as a bicoid-class homeodomain factor that binds and activates the POMC promoter in pituitary cells, and physically synergizes with Pit-1, established the founding molecular activity and first partnership for this transcription factor.","evidence":"Cloning from AtT-20 cells, DNA-binding assays, reporter assays, interaction-based cloning with Pit-1","pmids":["8675014","8755540"],"confidence":"High","gaps":["Genome-wide target repertoire in pituitary unknown","In vivo requirement not yet tested"]},{"year":1998,"claim":"Demonstration that PITX1 synergizes with SF-1 on the LHβ promoter and is required upstream of Lhx3 placed PITX1 at the apex of a pituitary transcriptional cascade, resolving its pan-pituitary regulatory role.","evidence":"Antisense knockdown in αT3-1 cells, co-transfection synergy assays across multiple promoters","pmids":["9514159"],"confidence":"High","gaps":["Conditional pituitary-specific knockout phenotype not yet described","Chromatin-level mechanism of synergy with SF-1 unresolved"]},{"year":1999,"claim":"Loss-of-function in mice and gain-of-function in chick jointly established PITX1 as the hindlimb identity determinant acting through Tbx4, HoxC10, and HoxC11, answering the fundamental question of what specifies hindlimb versus forelimb.","evidence":"Pitx1 knockout mice (two independent labs), retroviral misexpression in chick wing bud, skeletal and molecular analysis","pmids":["10101115","10049363","10073939"],"confidence":"High","gaps":["Direct versus indirect activation of Tbx4 not resolved at chromatin level","Enhancers controlling Pitx1 hindlimb-restricted expression not yet identified"]},{"year":1999,"claim":"Mapping the physical interaction between the PITX1 C-terminus and SF-1 N-terminus, and identifying Egr-1 as a GnRH-responsive factor that synergizes with PITX1 and SF-1, defined a tripartite transcriptional complex on the LHβ promoter linking extracellular signals to PITX1 function.","evidence":"Mammalian two-hybrid, domain-mapping mutagenesis, co-immunoprecipitation, PKC activation epistasis","pmids":["10369682","10082522"],"confidence":"High","gaps":["Structural basis of PITX1-SF-1 interface unknown","Whether Egr-1 directly bridges PITX1 and SF-1 or acts independently on DNA not resolved"]},{"year":2000,"claim":"Discovery that PITX1 represses IFN-A promoters via the DNRE, with the C-terminal and homeodomain required, revealed a transcriptional repressor function distinct from its activator role, broadening its regulatory repertoire to innate immunity.","evidence":"Yeast one-hybrid identification, EMSA, reporter assays, antisense knockdown in virus-stimulated cells","pmids":["11003649"],"confidence":"High","gaps":["Physiological relevance of IFN-A repression in antiviral immunity not tested in vivo"]},{"year":2002,"claim":"Identification of direct physical interaction between PITX1 homeodomain and IRF3/IRF7 clarified the mechanism of IFN-A repression as protein–protein sequestration rather than HDAC recruitment, distinguishing it mechanistically from other homeodomain repressors.","evidence":"Co-immunoprecipitation, domain-mapping mutagenesis, reporter assays, HDAC inhibitor experiments","pmids":["12242290"],"confidence":"High","gaps":["Genome-wide impact on interferon gene network not assessed","In vivo role in viral infection not demonstrated"]},{"year":2005,"claim":"An RNAi screen identified PITX1 as a suppressor of RAS signaling through transcriptional activation of RASAL1, establishing PITX1 as a tumor suppressor linking a developmental transcription factor to oncogenic pathway control.","evidence":"RNAi library screen, RAS-dependence epistasis test, soft-agar transformation, RASAL1 expression rescue in colon cancer cells","pmids":["15960973"],"confidence":"High","gaps":["Whether PITX1 loss activates RAS in non-colon cancer contexts not systematically tested","Direct ChIP on RASAL1 promoter not shown in this study"]},{"year":2007,"claim":"PITX1 was shown to directly bind and activate the p53 promoter, inducing p53-dependent cell-cycle arrest and apoptosis, revealing a second major tumor-suppressive output and explaining its growth-inhibitory effects in cancer cells.","evidence":"ChIP on p53 promoter, site-directed mutagenesis, siRNA knockdown, apoptosis assays in MCF-7 cells","pmids":["17762884"],"confidence":"High","gaps":["Whether PITX1-driven p53 activation is relevant in developmental contexts unclear","Relative contribution of RASAL1 vs. p53 to tumor suppression not dissected"]},{"year":2007,"claim":"DUX4 was identified as a direct transcriptional activator of PITX1, binding a TAAT-core element in the PITX1 promoter, establishing an upstream regulatory input relevant to FSHD pathology.","evidence":"EMSA, site-directed mutagenesis, luciferase reporter, endogenous PITX1 induction by qRT-PCR in C2C12 cells","pmids":["17984056"],"confidence":"High","gaps":["Whether DUX4-PITX1 axis operates in patient muscle in vivo not directly tested"]},{"year":2008,"claim":"A dominant-negative PITX1 homeodomain mutation (E130K) segregating with autosomal dominant clubfoot in a human family provided the first direct genetic link between PITX1 and human Mendelian limb malformation.","evidence":"Linkage analysis, luciferase reporter assays, dose-dependent suppression of wild-type PITX1 activity","pmids":["18950742"],"confidence":"High","gaps":["Structural basis of E130K dominant-negative effect not resolved","Additional PITX1 mutations in clubfoot cohorts not yet surveyed"]},{"year":2009,"claim":"Repeated pelvic loss in sticklebacks was mapped to regulatory deletions of the PelA pelvic enhancer of Pitx1, providing the first example of a tissue-specific enhancer deletion driving morphological evolution at a developmental transcription factor locus.","evidence":"Population genetics, enhancer deletion analysis, expression studies in sticklebacks","pmids":["20007865"],"confidence":"High","gaps":["Mammalian PelA ortholog function not tested","Whether PelA interacts with other enhancers in the Pitx1 locus unknown"]},{"year":2011,"claim":"Multiple studies converged to show that PITX1 directly suppresses hTERT transcription by binding conserved sites in the hTERT promoter, that Pitx1 haploinsufficiency causes clubfoot in mice paralleling the human phenotype, and that PITX1 selectively inhibits ERα/ERβ transcriptional activity while being estrogen-inducible, broadening the gene's functional scope to telomerase regulation, quantitative limb development, and hormone receptor modulation.","evidence":"ChIP and EMSA on hTERT promoter; Pitx1+/− mouse breeding with MRI and skeletal phenotyping; ChIP-Seq on ERα binding sites with siRNA in breast cancer cells","pmids":["21300782","21775501","21868451"],"confidence":"High","gaps":["Whether hTERT suppression and ERα modulation are connected remains untested","Mechanism by which PITX1 inhibits ERα but enhances PR/GR activity not resolved"]},{"year":2012,"claim":"Genome-wide ChIP-Seq in mouse hindlimbs directly confirmed Tbx4, HoxC10, and HoxC11 as direct PITX1 targets and revealed preferential binding to hindlimb-specific enhancers, resolving the long-standing question of direct versus indirect Tbx4 regulation.","evidence":"ChIP-Seq with H3K27ac chromatin marking in E12.5 mouse hindlimbs","pmids":["23201014"],"confidence":"High","gaps":["Time-resolved binding dynamics during limb specification not captured","Co-factor recruitment at hindlimb enhancers not identified"]},{"year":2013,"claim":"Discovery that RHAU helicase suppresses PITX1 protein expression post-transcriptionally through the miRNA/Ago2 pathway, without affecting mRNA levels, established a non-coding RNA-based regulatory layer controlling PITX1 abundance.","evidence":"RNA co-immunoprecipitation, siRNA knockdown of RHAU/Dicer/Ago2, Western blotting","pmids":["24369427"],"confidence":"High","gaps":["Specific miRNA(s) recruited by RHAU to PITX1 mRNA not identified","Physiological context in which RHAU-mediated suppression operates not defined"]},{"year":2016,"claim":"PTP1B was identified as a direct phosphatase that dephosphorylates PITX1 at Y160/Y175/Y179, destabilizing the protein and reducing its transcriptional activity on RasGAP targets, linking tyrosine phosphorylation to PITX1 protein turnover and tumor suppressor output.","evidence":"FLAG pull-down, phosphorylation site mapping, PTP1B inhibition/silencing, reporter assays, xenograft validation","pmids":["26840794"],"confidence":"High","gaps":["Kinase that phosphorylates PITX1 at these tyrosines not identified","Proteasomal versus other degradation pathway not determined"]},{"year":2017,"claim":"Integrated ChIP-Seq and RNA-Seq in Pitx1−/− hindlimbs identified ~440 direct targets including Sox9 and Six1, and showed PITX1 acts on similar chromatin states in both limbs, establishing that PITX1 redirects a generic limb program through a narrow set of hindlimb-restricted regulatory targets.","evidence":"ChIP-Seq, RNA-Seq in Pitx1−/− embryos, cross-species (mouse/Anolis) conservation analysis, H3K27ac chromatin profiling","pmids":["29273440","28807899"],"confidence":"High","gaps":["Single-cell resolution of target activation dynamics not achieved in these studies","Pioneer factor versus cooperative binding mechanism not distinguished"]},{"year":2018,"claim":"Identification and CRISPR-deletion of a second pelvic enhancer (PelB) downstream of Pitx1, and demonstration that H2AFY promoter deletion causes Liebenberg syndrome by unshielding the Pen enhancer from Pitx1 in forelimbs, revealed a multi-enhancer regulatory landscape with insulator-dependent limb-type specificity.","evidence":"Transgenic enhancer reporters, CRISPR deletion in mice, stickleback population genetics, whole-genome sequencing of Liebenberg syndrome patients","pmids":["30499775","30711920"],"confidence":"High","gaps":["Full 3D topology of enhancer–insulator interactions at Pitx1 locus not mapped at high resolution","Additional enhancers contributing to hindlimb expression may exist"]},{"year":2019,"claim":"PITX1 was shown to cooperate with SOX2 and TRP63 in a feed-forward circuit maintaining squamous cell carcinoma stem cell self-renewal, with KLF4 acting as a reciprocal repressor, revealing an oncogenic role for PITX1 in specific cancer contexts distinct from its tumor-suppressive functions.","evidence":"CRISPR knockout, ChIP-Seq, RNA-Seq, functional self-renewal assays in mouse and human SCC","pmids":["30713093"],"confidence":"High","gaps":["Whether the PITX1 tumor-suppressor and SCC self-renewal functions depend on different target gene subsets not resolved","Context determinants that switch PITX1 from suppressor to oncogenic factor unknown"]},{"year":2021,"claim":"Single-cell transcriptomics of Pen enhancer-deleted embryos showed that Pitx1 regulatory landscape disruption causes heterochronic loss of high-expressing cells and clubfoot through failure to coordinate multiple enhancer activities, linking 3D chromatin architecture to quantitative Pitx1 dosage control.","evidence":"Pen enhancer CRISPR deletion, single-cell RNA-Seq, in-embryo cell tracing, 3D chromatin analysis","pmids":["34903763"],"confidence":"High","gaps":["Whether PelA, PelB, and Pen act additively or synergistically on Pitx1 dosage not quantified","Upstream factors that coordinate enhancer activity remain unknown"]},{"year":null,"claim":"Key unresolved questions include: the kinase(s) that phosphorylate PITX1 at tyrosine residues counteracting PTP1B; the structural basis for context-dependent switching between activator and repressor functions; whether PITX1 acts as a pioneer factor or cooperative binder at developmental enhancers; and how its tumor-suppressive versus pro-self-renewal activities are determined by cellular context.","evidence":"","pmids":[],"confidence":"Low","gaps":["Tyrosine kinase phosphorylating PITX1 unidentified","No crystal structure of PITX1 homeodomain–DNA complex available","Pioneer versus cooperative binding mechanism at limb enhancers not distinguished","Molecular basis for context-dependent oncogenic vs. tumor-suppressive roles unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,10,11,18,22,26,39]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,10,16,18,22,24,36,39]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,42]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,4,5,25,26,33,34,40]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,31]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[18,27]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,12]}],"complexes":[],"partners":["PIT1","SF1","EGR1","IRF3","IRF7","ZCCHC10","HIF1B","SOX2"],"other_free_text":[]},"mechanistic_narrative":"PITX1 is a bicoid-related homeodomain transcription factor that functions as a master regulator of hindlimb identity, pituitary gene expression, tumor suppression, and innate immune gene modulation. In limb development, PITX1 directly activates Tbx4, HoxC10, HoxC11, Sox9, and Six1 to specify hindlimb morphology and drive chondrogenesis and myogenesis, with its tissue-restricted expression controlled by dedicated enhancers (PelA, PelB, Pen) whose deletion causes pelvic reduction and clubfoot [PMID:10049363, PMID:23201014, PMID:29273440, PMID:34903763]. In the pituitary, PITX1 activates POMC, LHβ, and other hormone gene promoters through synergistic physical interactions with Pit-1, SF-1, and Egr-1, while in cancer contexts it suppresses RAS signaling by transcriptionally activating RASAL1, directly activates p53 transcription, and represses hTERT in cooperation with ZCCHC10 [PMID:8675014, PMID:9514159, PMID:15960973, PMID:17762884, PMID:21300782]. PITX1 protein stability is regulated by PTP1B-mediated dephosphorylation at Y160/Y175/Y179 and its translation is suppressed by miR-19b and the RHAU helicase through 3′UTR-dependent mechanisms [PMID:26840794, PMID:25643913, PMID:24369427]. Dominant-negative mutations in the PITX1 homeodomain and haploinsufficiency cause autosomal dominant lower-limb malformations including clubfoot in humans and mice [PMID:18950742, PMID:21775501]."},"prefetch_data":{"uniprot":{"accession":"P78337","full_name":"Pituitary homeobox 1","aliases":["Hindlimb-expressed homeobox protein backfoot","Homeobox protein PITX1","Paired-like homeodomain transcription factor 1"],"length_aa":314,"mass_kda":34.1,"function":"Sequence-specific transcription factor that binds gene promoters and activates their transcription. May play a role in the development of anterior structures, and in particular, the brain and facies and in specifying the identity or structure of hindlimb","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P78337/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PITX1","classification":"Not Classified","n_dependent_lines":13,"n_total_lines":1208,"dependency_fraction":0.01076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PITX1","total_profiled":1310},"omim":[{"mim_id":"620472","title":"TRAFFICKING PROTEIN PARTICLE COMPLEX, SUBUNIT 2B; TRAPPC2B","url":"https://www.omim.org/entry/620472"},{"mim_id":"610054","title":"MACRO H2A.1 HISTONE; MACROH2A1","url":"https://www.omim.org/entry/610054"},{"mim_id":"606009","title":"DOUBLE HOMEOBOX PROTEIN 4; DUX4","url":"https://www.omim.org/entry/606009"},{"mim_id":"604614","title":"T-BOX TRANSCRIPTION FACTOR 19; TBX19","url":"https://www.omim.org/entry/604614"},{"mim_id":"602149","title":"PAIRED-LIKE HOMEODOMAIN TRANSCRIPTION FACTOR 1; PITX1","url":"https://www.omim.org/entry/602149"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoli","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"esophagus","ntpm":701.1},{"tissue":"vagina","ntpm":194.5}],"url":"https://www.proteinatlas.org/search/PITX1"},"hgnc":{"alias_symbol":["PTX1","POTX"],"prev_symbol":["BFT"]},"alphafold":{"accession":"P78337","domains":[{"cath_id":"1.10.10.60","chopping":"114-157","consensus_level":"high","plddt":91.1207,"start":114,"end":157}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P78337","model_url":"https://alphafold.ebi.ac.uk/files/AF-P78337-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P78337-F1-predicted_aligned_error_v6.png","plddt_mean":61.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PITX1","jax_strain_url":"https://www.jax.org/strain/search?query=PITX1"},"sequence":{"accession":"P78337","fasta_url":"https://rest.uniprot.org/uniprotkb/P78337.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P78337/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P78337"}},"corpus_meta":[{"pmid":"20007865","id":"PMC_20007865","title":"Adaptive evolution of pelvic reduction in sticklebacks by recurrent deletion of a Pitx1 enhancer.","date":"2009","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20007865","citation_count":739,"is_preprint":false},{"pmid":"10049363","id":"PMC_10049363","title":"Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10049363","citation_count":340,"is_preprint":false},{"pmid":"8675014","id":"PMC_8675014","title":"Ptx1, a bicoid-related homeo box transcription factor involved in transcription of the pro-opiomelanocortin gene.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8675014","citation_count":337,"is_preprint":false},{"pmid":"17984056","id":"PMC_17984056","title":"DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17984056","citation_count":297,"is_preprint":false},{"pmid":"9514159","id":"PMC_9514159","title":"The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3.","date":"1998","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9514159","citation_count":240,"is_preprint":false},{"pmid":"15960973","id":"PMC_15960973","title":"A genetic screen identifies PITX1 as a suppressor of RAS activity and tumorigenicity.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15960973","citation_count":237,"is_preprint":false},{"pmid":"10101115","id":"PMC_10101115","title":"Hindlimb patterning and mandible development require the Ptx1 gene.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10101115","citation_count":234,"is_preprint":false},{"pmid":"10073939","id":"PMC_10073939","title":"Role of Pitx1 upstream of Tbx4 in specification of hindlimb identity.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10073939","citation_count":232,"is_preprint":false},{"pmid":"10082522","id":"PMC_10082522","title":"Egr-1 is a downstream effector of GnRH and synergizes by direct interaction with Ptx1 and SF-1 to enhance luteinizing hormone beta gene transcription.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10082522","citation_count":225,"is_preprint":false},{"pmid":"8755540","id":"PMC_8755540","title":"P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8755540","citation_count":221,"is_preprint":false},{"pmid":"9226452","id":"PMC_9226452","title":"The bicoid-related homeoprotein Ptx1 defines the most anterior domain of the embryo and differentiates posterior from anterior lateral mesoderm.","date":"1997","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9226452","citation_count":186,"is_preprint":false},{"pmid":"10625557","id":"PMC_10625557","title":"Antagonistic signals between BMP4 and FGF8 define the expression of Pitx1 and Pitx2 in mouse tooth-forming anlage.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10625557","citation_count":168,"is_preprint":false},{"pmid":"20409005","id":"PMC_20409005","title":"BROTHER OF FT AND TFL1 (BFT) has TFL1-like activity and functions redundantly with TFL1 in inflorescence meristem development in Arabidopsis.","date":"2010","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20409005","citation_count":108,"is_preprint":false},{"pmid":"10369682","id":"PMC_10369682","title":"Ptx1 regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10369682","citation_count":107,"is_preprint":false},{"pmid":"18950742","id":"PMC_18950742","title":"Asymmetric lower-limb malformations in individuals with homeobox PITX1 gene mutation.","date":"2008","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18950742","citation_count":105,"is_preprint":false},{"pmid":"10067870","id":"PMC_10067870","title":"Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development.","date":"1999","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10067870","citation_count":88,"is_preprint":false},{"pmid":"18550679","id":"PMC_18550679","title":"Analysis and distribution of class 1 and class 2 integrons and associated gene cassettes among Escherichia coli isolates from swine, horses, cats and dogs collected in the BfT-GermVet monitoring study.","date":"2008","source":"The Journal of antimicrobial chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/18550679","citation_count":79,"is_preprint":false},{"pmid":"23935007","id":"PMC_23935007","title":"The Arabidopsis floral repressor BFT delays flowering by competing with FT for FD binding under high salinity.","date":"2013","source":"Molecular plant","url":"https://pubmed.ncbi.nlm.nih.gov/23935007","citation_count":77,"is_preprint":false},{"pmid":"10859489","id":"PMC_10859489","title":"Transcriptional properties of Ptx1 and Ptx2 isoforms.","date":"2000","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/10859489","citation_count":75,"is_preprint":false},{"pmid":"11328855","id":"PMC_11328855","title":"A single Pitx1 binding site is essential for activity of the LHbeta promoter in transgenic mice.","date":"2001","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/11328855","citation_count":75,"is_preprint":false},{"pmid":"24369427","id":"PMC_24369427","title":"The RNA helicase RHAU (DHX36) suppresses expression of the transcription factor PITX1.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24369427","citation_count":69,"is_preprint":false},{"pmid":"17762884","id":"PMC_17762884","title":"Transcriptional activation of p53 by Pitx1.","date":"2007","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/17762884","citation_count":65,"is_preprint":false},{"pmid":"21775501","id":"PMC_21775501","title":"Pitx1 haploinsufficiency causes clubfoot in humans and a clubfoot-like phenotype in mice.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21775501","citation_count":64,"is_preprint":false},{"pmid":"21300782","id":"PMC_21300782","title":"Identification of PITX1 as a TERT suppressor gene located on human chromosome 5.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21300782","citation_count":63,"is_preprint":false},{"pmid":"18096559","id":"PMC_18096559","title":"Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudintermedius detected in the BfT-GermVet monitoring programme 2004-2006 in Germany.","date":"2007","source":"The Journal of antimicrobial chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/18096559","citation_count":63,"is_preprint":false},{"pmid":"22438068","id":"PMC_22438068","title":"Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma.","date":"2012","source":"International journal of colorectal disease","url":"https://pubmed.ncbi.nlm.nih.gov/22438068","citation_count":62,"is_preprint":false},{"pmid":"25643913","id":"PMC_25643913","title":"miR-19b regulates hTERT mRNA expression through targeting PITX1 mRNA in melanoma cells.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/25643913","citation_count":59,"is_preprint":false},{"pmid":"10832652","id":"PMC_10832652","title":"Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes.","date":"2000","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10832652","citation_count":57,"is_preprint":false},{"pmid":"17307339","id":"PMC_17307339","title":"Molecular basis of resistance to macrolides and lincosamides among staphylococci and streptococci from various animal sources collected in the resistance monitoring program BfT-GermVet.","date":"2007","source":"International journal of antimicrobial agents","url":"https://pubmed.ncbi.nlm.nih.gov/17307339","citation_count":56,"is_preprint":false},{"pmid":"22071103","id":"PMC_22071103","title":"Pitx1 is necessary for normal initiation of hindlimb outgrowth through regulation of Tbx4 expression and shapes hindlimb morphologies via targeted growth control.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22071103","citation_count":50,"is_preprint":false},{"pmid":"9431811","id":"PMC_9431811","title":"Embryonic expression and characterization of a Ptx1 homolog in Drosophila.","date":"1997","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9431811","citation_count":49,"is_preprint":false},{"pmid":"23201014","id":"PMC_23201014","title":"Pitx1 broadly associates with limb enhancers and is enriched on hindlimb cis-regulatory elements.","date":"2012","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23201014","citation_count":49,"is_preprint":false},{"pmid":"18082678","id":"PMC_18082678","title":"Deletion of the Pitx1 genomic locus affects mandibular tooth morphogenesis and expression of the Barx1 and Tbx1 genes.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18082678","citation_count":49,"is_preprint":false},{"pmid":"10612750","id":"PMC_10612750","title":"A new subtype of the metalloprotease toxin gene and the incidence of the three bft subtypes among Bacteroides fragilis isolates in Japan.","date":"2000","source":"FEMS microbiology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10612750","citation_count":48,"is_preprint":false},{"pmid":"38437016","id":"PMC_38437016","title":"Microbiota enterotoxigenic Bacteroides fragilis-secreted BFT-1 promotes breast cancer cell stemness and chemoresistance through its functional receptor NOD1.","date":"2024","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/38437016","citation_count":47,"is_preprint":false},{"pmid":"8425899","id":"PMC_8425899","title":"ptx1, a nonphototactic mutant of Chlamydomonas, lacks control of flagellar dominance.","date":"1993","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8425899","citation_count":45,"is_preprint":false},{"pmid":"21685166","id":"PMC_21685166","title":"Analysis of bla(CTX-M)-carrying plasmids from Escherichia coli isolates collected in the BfT-GermVet study.","date":"2011","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21685166","citation_count":43,"is_preprint":false},{"pmid":"23125914","id":"PMC_23125914","title":"Conditional over-expression of PITX1 causes skeletal muscle dystrophy in mice.","date":"2012","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/23125914","citation_count":42,"is_preprint":false},{"pmid":"21809215","id":"PMC_21809215","title":"The floral repressor BROTHER OF FT AND TFL1 (BFT) modulates flowering initiation under high salinity in Arabidopsis.","date":"2011","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/21809215","citation_count":42,"is_preprint":false},{"pmid":"22258522","id":"PMC_22258522","title":"Deletions in PITX1 cause a spectrum of lower-limb malformations including mirror-image polydactyly.","date":"2012","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/22258522","citation_count":41,"is_preprint":false},{"pmid":"31493405","id":"PMC_31493405","title":"Circular RNA circ-PITX1 promotes the progression of glioblastoma by acting as a competing endogenous RNA to regulate miR-379-5p/MAP3K2 axis.","date":"2019","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31493405","citation_count":40,"is_preprint":false},{"pmid":"26840794","id":"PMC_26840794","title":"Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.","date":"2016","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/26840794","citation_count":37,"is_preprint":false},{"pmid":"30499775","id":"PMC_30499775","title":"A novel enhancer near the Pitx1 gene influences development and evolution of pelvic appendages in vertebrates.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30499775","citation_count":37,"is_preprint":false},{"pmid":"28369532","id":"PMC_28369532","title":"Three FT and multiple CEN and BFT genes regulate maturity, flowering, and vegetative phenology in kiwifruit.","date":"2017","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/28369532","citation_count":37,"is_preprint":false},{"pmid":"30713093","id":"PMC_30713093","title":"De Novo PITX1 Expression Controls Bi-Stable Transcriptional Circuits to Govern Self-Renewal and Differentiation in Squamous Cell Carcinoma.","date":"2019","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/30713093","citation_count":37,"is_preprint":false},{"pmid":"12011080","id":"PMC_12011080","title":"Multiple mechanisms for Pitx-1 transactivation of a luteinizing hormone beta subunit gene.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12011080","citation_count":36,"is_preprint":false},{"pmid":"10555539","id":"PMC_10555539","title":"Expression of Ptx1 in the adult rat pituitary glands and pituitary cell lines: hormone-secreting cells and folliculo-stellate cells.","date":"1999","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/10555539","citation_count":33,"is_preprint":false},{"pmid":"28807899","id":"PMC_28807899","title":"Pitx1 directly modulates the core limb development program to implement hindlimb identity.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28807899","citation_count":32,"is_preprint":false},{"pmid":"10655354","id":"PMC_10655354","title":"The alleles of the bft gene are distributed differently among enterotoxigenic Bacteroides fragilis strains from human sources and can be present in double copies.","date":"2000","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10655354","citation_count":31,"is_preprint":false},{"pmid":"32416163","id":"PMC_32416163","title":"Effect of acute exposure to ammonia and BFT alterations on Rhynchocypris lagowski: Digestive enzyme, inflammation response, oxidative stress and immunological parameters.","date":"2020","source":"Environmental toxicology and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/32416163","citation_count":30,"is_preprint":false},{"pmid":"38273425","id":"PMC_38273425","title":"Entero-toxigenic Bacteroides fragilis contributes to intestinal barrier injury and colorectal cancer progression by mediating the BFT/STAT3/ZEB2 pathway.","date":"2024","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/38273425","citation_count":28,"is_preprint":false},{"pmid":"21868451","id":"PMC_21868451","title":"The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21868451","citation_count":28,"is_preprint":false},{"pmid":"32344431","id":"PMC_32344431","title":"Mutations Upstream of the TBX5 and PITX1 Transcription Factor Genes Are Associated with Feathered Legs in the Domestic Chicken.","date":"2020","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/32344431","citation_count":28,"is_preprint":false},{"pmid":"11250922","id":"PMC_11250922","title":"Characterization of 5'-flanking region of rat somatostatin receptor sst2 gene: transcriptional regulatory elements and activation by Pitx1 and estrogen.","date":"2001","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11250922","citation_count":28,"is_preprint":false},{"pmid":"12180925","id":"PMC_12180925","title":"Modulation of bft expression by the Bacteroides fragilis pathogenicity island and its flanking region.","date":"2002","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12180925","citation_count":27,"is_preprint":false},{"pmid":"18053270","id":"PMC_18053270","title":"Association of autism with polymorphisms in the paired-like homeodomain transcription factor 1 (PITX1) on chromosome 5q31: a candidate gene analysis.","date":"2007","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18053270","citation_count":27,"is_preprint":false},{"pmid":"9337397","id":"PMC_9337397","title":"Human and murine PTX1/Ptx1 gene maps to the region for Treacher Collins syndrome.","date":"1997","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/9337397","citation_count":27,"is_preprint":false},{"pmid":"21425961","id":"PMC_21425961","title":"Activation of Paired-homeobox gene PITX1 by del(5)(q31) in T-cell acute lymphoblastic leukemia.","date":"2011","source":"Leukemia & lymphoma","url":"https://pubmed.ncbi.nlm.nih.gov/21425961","citation_count":25,"is_preprint":false},{"pmid":"16701617","id":"PMC_16701617","title":"The distribution of the bft alleles among enterotoxigenic Bacteroides fragilis strains from stool specimens and extraintestinal sites.","date":"2005","source":"Anaerobe","url":"https://pubmed.ncbi.nlm.nih.gov/16701617","citation_count":25,"is_preprint":false},{"pmid":"9186008","id":"PMC_9186008","title":"Flagellar photoresponses of ptx1, a nonphototactic mutant of Chlamydomonas.","date":"1997","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/9186008","citation_count":24,"is_preprint":false},{"pmid":"30549141","id":"PMC_30549141","title":"MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.","date":"2019","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/30549141","citation_count":23,"is_preprint":false},{"pmid":"29273440","id":"PMC_29273440","title":"PITX1 promotes chondrogenesis and myogenesis in mouse hindlimbs through conserved regulatory targets.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29273440","citation_count":23,"is_preprint":false},{"pmid":"23587911","id":"PMC_23587911","title":"Liebenberg syndrome is caused by a deletion upstream to the PITX1 gene resulting in transformation of the upper limbs to reflect lower limb characteristics.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23587911","citation_count":23,"is_preprint":false},{"pmid":"35796629","id":"PMC_35796629","title":"CRISPR-Cas9-mediated mutagenesis of kiwifruit BFT genes results in an evergrowing but not early flowering phenotype.","date":"2022","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/35796629","citation_count":22,"is_preprint":false},{"pmid":"21964592","id":"PMC_21964592","title":"PITX2 AND PITX1 regulate thyrotroph function and response to hypothyroidism.","date":"2011","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21964592","citation_count":22,"is_preprint":false},{"pmid":"31260797","id":"PMC_31260797","title":"MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.","date":"2019","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/31260797","citation_count":22,"is_preprint":false},{"pmid":"29743058","id":"PMC_29743058","title":"Abnormal PITX1 gene methylation in adolescent idiopathic scoliosis: a pilot study.","date":"2018","source":"BMC musculoskeletal disorders","url":"https://pubmed.ncbi.nlm.nih.gov/29743058","citation_count":21,"is_preprint":false},{"pmid":"35456219","id":"PMC_35456219","title":"Serum Proteins, HMMR, NXPH4, PITX1 and THBS4; A Panel of Biomarkers for Early Diagnosis of Hepatocellular Carcinoma.","date":"2022","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35456219","citation_count":21,"is_preprint":false},{"pmid":"20498720","id":"PMC_20498720","title":"SEDLIN forms homodimers: characterisation of SEDLIN mutations and their interactions with transcription factors MBP1, PITX1 and SF1.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20498720","citation_count":21,"is_preprint":false},{"pmid":"30844502","id":"PMC_30844502","title":"The presence of antibiotic resistance genes and bft genes as well as antibiotic susceptibility testing of Bacteroides fragilis strains isolated from inpatients of the Infant Jesus Teaching Hospital, Warsaw during 2007-2012.","date":"2019","source":"Anaerobe","url":"https://pubmed.ncbi.nlm.nih.gov/30844502","citation_count":21,"is_preprint":false},{"pmid":"36892416","id":"PMC_36892416","title":"CRISPR/Cas9 mutants delineate roles of Populus FT and TFL1/CEN/BFT family members in growth, dormancy release and flowering.","date":"2023","source":"Tree physiology","url":"https://pubmed.ncbi.nlm.nih.gov/36892416","citation_count":20,"is_preprint":false},{"pmid":"30711920","id":"PMC_30711920","title":"H2AFY promoter deletion causes PITX1 endoactivation and Liebenberg syndrome.","date":"2019","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30711920","citation_count":20,"is_preprint":false},{"pmid":"31404068","id":"PMC_31404068","title":"PITX1 protein interacts with ZCCHC10 to regulate hTERT mRNA transcription.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31404068","citation_count":20,"is_preprint":false},{"pmid":"27802335","id":"PMC_27802335","title":"E2F1 and TFDP1 Regulate PITX1 Expression in Normal and Osteoarthritic Articular Chondrocytes.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27802335","citation_count":20,"is_preprint":false},{"pmid":"17301286","id":"PMC_17301286","title":"Determination of bft gene subtypes in Bacteroides fragilis clinical isolates.","date":"2007","source":"Journal of clinical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/17301286","citation_count":20,"is_preprint":false},{"pmid":"12242290","id":"PMC_12242290","title":"Repression by homeoprotein pitx1 of virus-induced interferon a promoters is mediated by physical interaction and trans repression of IRF3 and IRF7.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12242290","citation_count":19,"is_preprint":false},{"pmid":"26649896","id":"PMC_26649896","title":"Biophysical Characterization of G-Quadruplex Recognition in the PITX1 mRNA by the Specificity Domain of the Helicase RHAU.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26649896","citation_count":19,"is_preprint":false},{"pmid":"11477694","id":"PMC_11477694","title":"Pitx1 and Pitx2c are required for ectopic cement gland formation in Xenopus laevis.","date":"2001","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/11477694","citation_count":19,"is_preprint":false},{"pmid":"34903763","id":"PMC_34903763","title":"Cell-specific alterations in Pitx1 regulatory landscape activation caused by the loss of a single enhancer.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34903763","citation_count":18,"is_preprint":false},{"pmid":"33727831","id":"PMC_33727831","title":"Circ-PITX1 Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1248/CCND2 Axis.","date":"2021","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33727831","citation_count":18,"is_preprint":false},{"pmid":"20930566","id":"PMC_20930566","title":"BROTHER OF FT AND TFL1 (BFT), a member of the FT/TFL1 family, shows distinct pattern of expression during the vegetative growth of Arabidopsis.","date":"2010","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/20930566","citation_count":18,"is_preprint":false},{"pmid":"9070926","id":"PMC_9070926","title":"Backfoot, a novel homeobox gene, maps to human chromosome 5 (BFT) and mouse chromosome 13 (Bft).","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9070926","citation_count":18,"is_preprint":false},{"pmid":"35007184","id":"PMC_35007184","title":"The circ-PITX1 promotes non-small cell lung cancer development via the miR-30e-5p/ITGA6 axis.","date":"2022","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/35007184","citation_count":17,"is_preprint":false},{"pmid":"11003649","id":"PMC_11003649","title":"Repression of virus-induced interferon A promoters by homeodomain transcription factor Ptx1.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11003649","citation_count":17,"is_preprint":false},{"pmid":"25558831","id":"PMC_25558831","title":"PITX1, a specificity determinant in the HIF-1α-mediated transcriptional response to hypoxia.","date":"2014","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25558831","citation_count":17,"is_preprint":false},{"pmid":"29549111","id":"PMC_29549111","title":"Disrupting the three-dimensional regulatory topology of the Pitx1 locus results in overtly normal development.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29549111","citation_count":16,"is_preprint":false},{"pmid":"34038721","id":"PMC_34038721","title":"Immunity-longevity tradeoff neurally controlled by GABAergic transcription factor PITX1/UNC-30.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34038721","citation_count":16,"is_preprint":false},{"pmid":"12620797","id":"PMC_12620797","title":"Modulation of interferon expression by hepatitis C virus NS5A protein and human homeodomain protein PTX1.","date":"2003","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/12620797","citation_count":16,"is_preprint":false},{"pmid":"25190136","id":"PMC_25190136","title":"miR‑886‑3p upregulation in clear cell renal cell carcinoma regulates cell migration, proliferation and apoptosis by targeting PITX1.","date":"2014","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25190136","citation_count":16,"is_preprint":false},{"pmid":"24232919","id":"PMC_24232919","title":"Morpholino treatment improves muscle function and pathology of Pitx1 transgenic mice.","date":"2013","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24232919","citation_count":15,"is_preprint":false},{"pmid":"32759168","id":"PMC_32759168","title":"The transcription factor PITX1 drives astrocyte differentiation by regulating the SOX9 gene.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32759168","citation_count":15,"is_preprint":false},{"pmid":"17549029","id":"PMC_17549029","title":"New emerging role of pitx1 transcription factor in osteoarthritis pathogenesis.","date":"2007","source":"Clinical orthopaedics and related research","url":"https://pubmed.ncbi.nlm.nih.gov/17549029","citation_count":15,"is_preprint":false},{"pmid":"36334221","id":"PMC_36334221","title":"PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization.","date":"2022","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/36334221","citation_count":15,"is_preprint":false},{"pmid":"37841446","id":"PMC_37841446","title":"PITX1 plays essential functions in cancer.","date":"2023","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37841446","citation_count":14,"is_preprint":false},{"pmid":"14512705","id":"PMC_14512705","title":"Pitx1 in vivo promoter activity and mechanisms of positive autoregulation.","date":"2003","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/14512705","citation_count":14,"is_preprint":false},{"pmid":"31783149","id":"PMC_31783149","title":"Overexpression of Pitx1 attenuates the senescence of chondrocytes from osteoarthritis degeneration cartilage-A self-controlled model for studying the etiology and treatment of osteoarthritis.","date":"2019","source":"Bone","url":"https://pubmed.ncbi.nlm.nih.gov/31783149","citation_count":14,"is_preprint":false},{"pmid":"25936343","id":"PMC_25936343","title":"Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25936343","citation_count":14,"is_preprint":false},{"pmid":"10902805","id":"PMC_10902805","title":"Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10902805","citation_count":14,"is_preprint":false},{"pmid":"38239306","id":"PMC_38239306","title":"Biofloc Technology (BFT) in Aquaculture: What Goes Right, What Goes Wrong? A Scientific-Based Snapshot.","date":"2024","source":"Aquaculture nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/38239306","citation_count":13,"is_preprint":false},{"pmid":"27330773","id":"PMC_27330773","title":"PITX1 is a novel predictor of the response to chemotherapy in head and neck squamous cell carcinoma.","date":"2016","source":"Molecular and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/27330773","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49474,"output_tokens":9921,"usd":0.148618},"stage2":{"model":"claude-opus-4-6","input_tokens":13935,"output_tokens":4724,"usd":0.281662},"total_usd":0.43028,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"PITX1 (Ptx1) is a bicoid-related homeodomain transcription factor that activates transcription of the POMC gene by binding sequences related to Drosophila bicoid target sites in a pituitary-cell-specific manner.\",\n      \"method\": \"Transcription factor cloning from AtT-20 cells, DNA-binding assays, reporter gene assays, in situ hybridization\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — original cloning with DNA-binding and transactivation assays, foundational paper with >300 citations\",\n      \"pmids\": [\"8675014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"PITX1 (P-OTX) physically interacts with the transactivation domain of the pituitary-specific POU domain protein Pit-1, and synergizes with Pit-1 to activate pituitary-specific target gene promoters.\",\n      \"method\": \"Interaction-based cloning, co-activation reporter assays in pituitary cell lines\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction identified by protein-interaction screen and functional synergy assays, >200 citations\",\n      \"pmids\": [\"8755540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"PITX1 acts as a pan-pituitary transcriptional activator that synergizes with SF-1 on the LHβ promoter and with Pit1 on the PRL promoter; antisense depletion shows the downstream Lim3/Lhx3 gene is highly dependent on PITX1, placing PITX1 upstream of Lhx3 in a pituitary transcriptional cascade.\",\n      \"method\": \"Reporter gene assays, antisense RNA knockdown in αT3-1 cells, co-transfection synergy assays\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis established by antisense knockdown with defined target-gene readout, replicated across multiple promoters, >240 citations\",\n      \"pmids\": [\"9514159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pitx1 gene deletion in mice causes severe hindlimb morphogenesis defects (absent ilium, underdeveloped long bones, loss of knee cartilage) with decreased Tbx4 expression in the hindlimb, demonstrating Pitx1 is required upstream of Tbx4 for hindlimb identity and chondrogenesis.\",\n      \"method\": \"Targeted gene knockout in mice, in situ hybridization, skeletal analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined morphological and molecular phenotype, independently corroborated by Szeto et al. 1999, >230 citations\",\n      \"pmids\": [\"10101115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pitx1 gene deletion causes striking hindlimb abnormalities (tibia/fibula and patella defects resembling forelimb) with decreased distal Tbx4 expression; misexpression of Pitx1 in chick wing bud induces Tbx4 and causes hindlimb-like digit morphology, establishing Pitx1 as a hindlimb identity determinant acting through Tbx4.\",\n      \"method\": \"Mouse knockout, chick limb misexpression (retroviral), skeletal morphology analysis, in situ hybridization\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — loss-of-function and gain-of-function in two species with defined molecular target, >340 citations\",\n      \"pmids\": [\"10049363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Misexpression of Pitx1 in the chick wing bud induces distal expression of Tbx4, HoxC10, and HoxC11, and transforms wing morphology toward hindlimb characteristics, placing Pitx1 upstream of Tbx4 in the hindlimb identity pathway.\",\n      \"method\": \"Retroviral misexpression in chick wing bud, in situ hybridization, morphological analysis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with defined molecular targets, independently replicated, >230 citations\",\n      \"pmids\": [\"10073939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PITX1 C-terminus directly interacts with the N-terminal half of SF-1; this physical interaction enhances SF-1 transcriptional activity on LHβ and MIS promoters to a level equivalent to a constitutively active SF-1 mutant, mimicking the effect of an SF-1 ligand.\",\n      \"method\": \"Mammalian two-hybrid assay, reporter gene assays, domain-mapping mutagenesis, co-transfection\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct protein–protein interaction mapped with mutagenesis and functional consequence defined, >100 citations\",\n      \"pmids\": [\"10369682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"GnRH induces Egr-1 expression (but not Pitx1 or SF-1); Egr-1 then directly interacts with Pitx1 and SF-1, enhancing Pitx1- and SF-1-induced LHβ transcription, establishing Egr-1 as a GnRH-responsive transcriptional mediator that functions through physical interaction with PITX1.\",\n      \"method\": \"Reporter gene assays, PKC activation, direct protein interaction assays (co-immunoprecipitation/pull-down implied), synergy assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct physical interaction plus functional synergy with signal-pathway epistasis, >225 citations\",\n      \"pmids\": [\"10082522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PITX1 is expressed in all pituitary cell types but at differentially quantitative levels; highest expression correlates with α-glycoprotein subunit-expressing cells throughout pituitary development, as shown by co-immunolocalization.\",\n      \"method\": \"Immunohistochemistry, co-immunolocalization, differential mRNA/protein quantification\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — localization with functional implication but no direct functional manipulation\",\n      \"pmids\": [\"10067870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FGF8 can induce/maintain Pitx1 and Pitx2 expression in the developing mandible, while BMP4 represses Pitx1 expression in mandibular mesenchyme, as shown by bead implantation experiments establishing antagonistic FGF8/BMP4 regulation of Pitx1.\",\n      \"method\": \"Bead implantation experiments in mouse embryos, in situ hybridization\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo gain/loss of signaling with defined Pitx1 expression readout\",\n      \"pmids\": [\"10625557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Pitx1 represses virus-induced IFN-A promoters by binding to the distal negative regulatory element (DNRE); the C-terminal region and homeodomain of Pitx1 are required for repression; antisense Pitx1 increases endogenous IFN-A transcription.\",\n      \"method\": \"Yeast one-hybrid (DNRE-binding protein identification), reporter assays, antisense RNA, EMSA, domain-mapping mutagenesis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — DNA binding demonstrated, functional domains mapped, antisense loss-of-function confirms endogenous role\",\n      \"pmids\": [\"11003649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A single Pitx1 binding site in the LHβ promoter is absolutely required for promoter activity in transgenic mice; mutation of this element abolishes both basal activity and GnRH responsiveness, demonstrating that cooperative interactions between Pitx1, SF-1, and Egr-1 depend on Pitx1 DNA binding in vivo.\",\n      \"method\": \"Transgenic mouse reporter assays, transient transfection in LβT2 gonadotrope-derived cells, site-directed mutagenesis\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo transgenic validation with mutagenesis, defining essential cis-regulatory requirement\",\n      \"pmids\": [\"11328855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PITX1 physically interacts with IRF3 and IRF7 via its homeodomain; specific C-terminal domains of Pitx1 mediate trans-repression of IFN-A11 and IFN-A5 (but not IFN-A4) promoter activities, and this repression is not mediated by histone deacetylase recruitment.\",\n      \"method\": \"Co-immunoprecipitation, domain-mapping mutagenesis, reporter gene assays, EMSA\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct physical interaction with functional domain mapping, mechanism of repression distinguished from HDAC pathway\",\n      \"pmids\": [\"12242290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pitx1 can homodimerize, phosphorylates on three residues when DNA-bound, and acts through multiple mechanisms on the LHβ promoter including synergy with SF-1 and estrogen receptor, binding to four upstream Pitx1 response elements, and inducing conformational changes in the DNA as shown by circular permutation assay.\",\n      \"method\": \"Mammalian two-hybrid (homodimerization), circular permutation assay (DNA bending), phosphorylation analysis, reporter gene assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mechanisms demonstrated in a single study but limited independent replication\",\n      \"pmids\": [\"12011080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PITX1 positively autoregulates its own promoter in a DNA-binding- and transactivation-domain-dependent manner; Pitx1, Pitx1b, Pitx2, and Otx1 all activate the PITX1 promoter in transfection assays, while transgenic mouse studies show that PITX1 promoter fragments reproduce anterior (but not posterior) expression.\",\n      \"method\": \"Transgenic mouse reporter assays, transient transfection, domain-mapping mutagenesis\",\n      \"journal\": \"Neuroendocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional promoter characterization with domain mapping in transgenic mice\",\n      \"pmids\": [\"14512705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"HCV NS5A protein physically interacts with human PITX1 (hPTX1) as identified by yeast two-hybrid and confirmed by mammalian two-hybrid, co-immunoprecipitation, and colocalization; co-expression of NS5A and hPTX1 reduces IFN-α promoter activity compared to either alone.\",\n      \"method\": \"Yeast two-hybrid, mammalian two-hybrid, co-immunoprecipitation, colocalization, reporter assays\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods confirming interaction, but single lab study\",\n      \"pmids\": [\"12620797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PITX1 suppresses RAS pathway activity and tumorigenicity by transcriptionally activating RASAL1, a RAS-GTPase-activating protein; knockdown of PITX1 activates RAS signaling and transforms human primary cells, while restoration of PITX1 in colon cancer cells inhibits tumorigenicity in a wild-type RAS-dependent manner.\",\n      \"method\": \"RNAi library screen, reporter assays, soft-agar transformation assay, expression analysis, epistasis (RAS-dependence test)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with defined molecular target (RASAL1), functional rescue assays, >237 citations\",\n      \"pmids\": [\"15960973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DUX4 protein directly binds a 30-bp sequence in the PITX1 promoter (TAAT core required) and transcriptionally activates both a PITX1 luciferase reporter and the endogenous PITX1 gene in C2C12 cells.\",\n      \"method\": \"Luciferase reporter assays, EMSA, site-directed mutagenesis of TAAT core, qRT-PCR of endogenous PITX1\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct DNA binding by EMSA with mutagenesis plus endogenous gene activation confirmed\",\n      \"pmids\": [\"17984056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PITX1 directly activates transcription of the p53 gene by binding to two PITX1 consensus elements in the p53 promoter, including one within the first exon; forced PITX1 expression causes p53-dependent cell-cycle arrest and apoptosis in MCF-7 cells, and PITX1 siRNA reduces basal p53 expression.\",\n      \"method\": \"Luciferase reporter assays, ChIP, site-directed mutagenesis, siRNA knockdown, apoptosis assays, dominant-negative PITX1\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding by ChIP + mutagenesis + loss-of-function with defined p53-dependent phenotype\",\n      \"pmids\": [\"17762884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Bone morphogenetic protein-4 (BMP4) down-regulates Pitx1 expression in both mandibular mesenchyme and dental epithelium, as shown by tissue recombination and bead implantation experiments; Pitx1 deletion results in decreased Barx1 expression in molar mesenchyme and suppression of Tbx1 in dental epithelium.\",\n      \"method\": \"Tissue recombination, bead implantation, in situ hybridization, Pitx1-/- mouse analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo signaling manipulation plus KO phenotype with molecular readouts\",\n      \"pmids\": [\"18082678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A missense mutation in the PITX1 homeodomain (E130K) reduces PITX1 transactivation activity in luciferase reporter assays and suppresses wild-type PITX1 activity in a dose-dependent manner, indicating dominant-negative effects; this mutation segregates with autosomal dominant lower-limb malformations including clubfoot.\",\n      \"method\": \"Luciferase reporter assay, dominant-negative suppression assay, linkage analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — defined molecular mechanism (dominant-negative) demonstrated functionally in human disease mutation\",\n      \"pmids\": [\"18950742\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pelvic loss in threespine sticklebacks evolves repeatedly through regulatory mutations deleting a tissue-specific pelvic enhancer of Pitx1 (PelA), reducing Pitx1 expression selectively in pelvic tissue without affecting the rest of Pitx1 expression; this represents an enhancer-based mechanism for morphological evolution.\",\n      \"method\": \"Population genetics, enhancer deletion analysis, expression studies, sequence analysis for selection signatures\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — natural deletion of a defined enhancer with expression and morphological phenotype, >739 citations\",\n      \"pmids\": [\"20007865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PITX1 suppresses hTERT transcription by directly binding to conserved binding sites in the hTERT promoter (three sites in hTERT, one in mouse Tert), as shown by in vitro and in vivo (ChIP) binding assays, ultimately reducing telomerase activity.\",\n      \"method\": \"Microcell-mediated chromosome transfer, cDNA microarray, luciferase reporter assays, EMSA (in vitro binding), ChIP (in vivo binding)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct promoter binding by both EMSA and ChIP, functional suppression of telomerase activity demonstrated\",\n      \"pmids\": [\"21300782\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Pitx1 haploinsufficiency causes clubfoot in mice with 8.9% penetrance; the affected hindlimb shows peroneal artery hypoplasia and reduced lateral muscle compartments; skeletal muscle gene expression is significantly reduced in Pitx1-/- E12.5 hindlimb buds, indicating early muscle developmental defects.\",\n      \"method\": \"Pitx1 heterozygous mouse breeding, copy number analysis in human patients, MRI, skeletal phenotyping, gene expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — haploinsufficiency model with quantitative molecular and morphological phenotype, human genetic validation\",\n      \"pmids\": [\"21775501\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PITX1 expression is robustly induced by estradiol (E2) in ERα-positive breast cancer cells via ERα-dependent interaction between the PITX1 proximal promoter and an upstream enhancer; PITX1 selectively inhibits ERα and ERβ transcriptional activity while enhancing glucocorticoid and progesterone receptor activities, and PITX1 is co-recruited with ERα to ERα binding sites.\",\n      \"method\": \"ChIP, reporter assays, siRNA knockdown, genome-wide ERα binding site analysis\",\n      \"journal\": \"Molecular endocrinology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-confirmed direct recruitment, functional siRNA knockdown showing ERα target gene regulation\",\n      \"pmids\": [\"21868451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Pitx1 is necessary for normal hindlimb outgrowth by regulating Tbx4 expression levels; a transgenic gene replacement strategy uncouples two discrete functions: (1) influencing hindlimb outgrowth through Tbx4 regulation, and (2) shaping hindlimb bone/soft tissue morphology independently of Tbx4, via localized modulation of growth rate of skeletal elements.\",\n      \"method\": \"Transgenic Pitx1 rescue in Pitx1-/- background, skeletal morphometry, molecular expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic dissection of two functional outputs using transgenic rescue, clean epistasis\",\n      \"pmids\": [\"22071103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Genome-wide ChIP-Seq in mouse hindlimbs shows Pitx1 binding is significantly enriched near limb morphogenesis genes including Tbx4, HoxC10, and HoxC11; Pitx1 is directly bound to the HLEA and HLEB hindlimb enhancers of Tbx4 and a Tbx2 hindlimb enhancer; Pitx1 binding is significantly enriched on hindlimb-specific vs. forelimb-specific cis-regulatory elements.\",\n      \"method\": \"ChIP-Seq, H3K27ac chromatin marking, genome-wide analysis of limb enhancers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide direct binding data with enhancer-level resolution confirming Tbx4 as a direct target\",\n      \"pmids\": [\"23201014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Conditional muscle-specific overexpression of PITX1 in mice causes skeletal muscle dystrophy (weight loss, muscle mass reduction, atrophic fibers, necrosis, inflammation) with upregulation of p53 in affected muscles, suggesting PITX1 drives atrophy through p53-dependent pathways.\",\n      \"method\": \"Tet-repressible transgenic mouse model, histopathology, immunoblotting, immunohistochemistry, grip strength testing\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — inducible transgenic overexpression with defined phenotype and molecular mechanism (p53 pathway)\",\n      \"pmids\": [\"23125914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The RNA helicase RHAU (DHX36) binds the PITX1 mRNA via a non-quadruplex-forming region and suppresses PITX1 protein expression post-transcriptionally through microRNA machinery (requiring Dicer and Argonaute-2) without substantially affecting mRNA levels.\",\n      \"method\": \"RNA co-immunoprecipitation, siRNA knockdown of RHAU/Dicer/Ago2, Western blotting, RNA G-quadruplex characterization\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal knockdown experiments defining the RHAU-miRNA-Ago2 regulatory mechanism on PITX1 translation\",\n      \"pmids\": [\"24369427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PITX1 associates with HIF-1β and is required for HIF-1α-dependent induction of specific histone demethylases (JMJD2B, JMJD2A, JMJD2C, JMJD1B) but not all HIF-1 target genes; PITX1-depleted cells show increased apoptosis and reduced proliferation under hypoxia.\",\n      \"method\": \"Co-immunoprecipitation (PITX1-HIF-1β interaction), siRNA knockdown, gene expression analysis, apoptosis/proliferation assays\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction plus loss-of-function with defined transcriptional and cellular phenotypes, single lab\",\n      \"pmids\": [\"25558831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-19b directly inhibits PITX1 mRNA translation through a binding site in the 3'UTR of PITX1 mRNA, leading to increased hTERT expression; overexpression of miR-19b reduces PITX1 protein without substantially affecting mRNA, establishing miR-19b as an upstream regulator of the PITX1-hTERT suppressor axis.\",\n      \"method\": \"miR-19b overexpression, 3'UTR luciferase reporter assays, Western blotting, qRT-PCR\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'UTR target validation with functional downstream consequences, single lab\",\n      \"pmids\": [\"25643913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PTP1B directly dephosphorylates PITX1 at Y160, Y175, and Y179, destabilizing PITX1 protein; PTP1B-dependent reduction in PITX1 decreases its transcriptional activity on the p120RasGAP (RASA1) promoter; PTP1B inhibition or sorafenib treatment hyperphosphorylates PITX1 and upregulates the PITX1-p120RasGAP axis.\",\n      \"method\": \"FLAG pull-down, phosphorylation site mapping, PTP1B inhibition, PTP1B silencing, reporter assays, molecular docking, in vivo xenograft\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct enzymatic dephosphorylation with specific phosphorylation sites identified, functional consequences on PITX1 stability and transcriptional activity, in vitro and in vivo validation\",\n      \"pmids\": [\"26840794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"E2F1, in complex with its dimerization partner TFDP1, directly activates PITX1 transcription by binding to two specific sequences in the PITX1 proximal promoter, as confirmed by ChIP and DNA pulldown; TFDP1 knockdown reduces both PITX1 promoter activity and mRNA levels in articular chondrocytes.\",\n      \"method\": \"Luciferase reporter assays, ChIP, DNA pulldown, siRNA knockdown (TFDP1)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding confirmed by ChIP and DNA pulldown with functional promoter assays\",\n      \"pmids\": [\"27802335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"ChIP-Seq and RNA-Seq in Pitx1-/- mouse hindlimbs identify 440 candidate direct PITX1 targets; 68 are ultra-conserved between mouse and Anolis lizard hindlimbs, including Sox9 and Six1, indicating PITX1 directly promotes chondrogenesis and myogenesis by activating key members of cartilage and muscle transcriptional networks.\",\n      \"method\": \"ChIP-Seq, RNA-Seq in Pitx1-/- embryos, cross-species (mouse/Anolis) comparison\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide direct binding combined with KO transcriptomics, cross-species conservation supports functional relevance\",\n      \"pmids\": [\"29273440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Expression profiling and direct Pitx1 target analysis show Pitx1 acts on sites in a similar chromatin state in both forelimb and hindlimb, controlling both patterning genes and the chondrogenic program, consistent with impaired chondrogenesis in Pitx1-/- hindlimbs; Pitx1 operates within a narrow network of hindlimb-restricted regulators to redirect the generic limb program.\",\n      \"method\": \"RNA-Seq, ChIP-Seq, H3K27ac chromatin profiling in FL/HL, Pitx1-/- analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide direct target identification with chromatin state analysis and KO validation\",\n      \"pmids\": [\"28807899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A newly identified pelvic enhancer (PelB) downstream of Pitx1 drives expression in the posterior hindlimb; PelB deletion in mice reduces hindlimb structure size; a wild stickleback population lacking the pelvis has an insertion/deletion disrupting PelB, showing this ancient enhancer contributes to evolutionary pelvic appendage modification.\",\n      \"method\": \"Transgenic enhancer reporter assay, CRISPR deletion in mice, skeletal phenotyping, stickleback population genetics\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — enhancer deletion in mouse with defined morphological phenotype plus natural variant validation\",\n      \"pmids\": [\"30499775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PITX1 cooperates with SOX2 and TRP63 in squamous cell carcinoma tumor propagating cells to sustain a transcriptional feed-forward circuit that maintains self-renewal while repressing KLF4-dependent differentiation; PITX1 knockdown inhibits self-renewal and KLF4 overexpression represses PITX1/SOX2/TRP63 expression, forming a bistable network.\",\n      \"method\": \"Gene targeting (CRISPR), ChIP-Seq, RNA-Seq, functional self-renewal assays in mouse and human SCC\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-Seq, KO, and transcriptomic analysis with functional cellular assays defining circuit architecture\",\n      \"pmids\": [\"30713093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PITX1 interacts with ZCCHC10 via its homeodomain; co-expression of PITX1 and ZCCHC10 cooperatively suppresses hTERT transcription in melanoma cells; homeodomain-deleted PITX1 cannot interact with ZCCHC10 and does not suppress hTERT, identifying PITX1-ZCCHC10 as a functional transcriptional repressor complex.\",\n      \"method\": \"FLAG pull-down assay, co-expression functional assays, deletion mutagenesis of homeodomain, qRT-PCR\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct interaction confirmed by pull-down with domain-mapping, functional outcome measured, single lab\",\n      \"pmids\": [\"31404068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"H2AFY promoter deletion causes ectopic Pitx1 expression in forelimbs (Liebenberg syndrome) because the H2AFY promoter insulates the Pen hindlimb enhancer from Pitx1 in forelimbs; loss of this insulation allows the pan-limb active Pen enhancer to drive Pitx1 in forelimbs, demonstrated by CRISPR-Cas9 re-engineering of the human deletion in mouse.\",\n      \"method\": \"Whole genome sequencing (human patients), CRISPR-Cas9 engineering in mouse, expression analysis\",\n      \"journal\": \"Journal of medical genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — precise in vivo genome editing recapitulating the human deletion with mechanistic explanation of enhancer insulation\",\n      \"pmids\": [\"30711920\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PITX1 drives astrocyte differentiation from human embryonic stem cells by directly activating the SOX9 promoter through a unique binding motif; PITX1 overexpression accelerates astrocyte differentiation and increases SOX9 expression, while PITX1 knockdown blocks differentiation and reduces SOX9.\",\n      \"method\": \"Luciferase reporter assays, EMSA, ChIP, siRNA knockdown, overexpression, human ESC differentiation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct SOX9 promoter binding by EMSA and ChIP, loss- and gain-of-function with defined cellular differentiation phenotype\",\n      \"pmids\": [\"32759168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Deletion of the Pen enhancer disrupts the Pitx1 regulatory landscape: single-cell transcriptomics and in-embryo cell tracing show increased fraction of Pitx1 non/low-expressing cells and loss of Pitx1 high-expressing cells, due to failure to coordinate enhancer activities and 3D chromatin changes, leading to a localized heterochrony, loss of irregular connective tissue, and a clubfoot phenotype.\",\n      \"method\": \"Pen enhancer deletion, single-cell RNA-Seq, in-embryo cell tracing, 3D chromatin analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — precise enhancer deletion with single-cell resolution phenotyping revealing regulatory landscape coordination mechanism\",\n      \"pmids\": [\"34903763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PITX1 interacts with STAT3 transcription factor, leading to decreased STAT3 transcriptional activity, which represses LINC00662 expression; PITX1 knockdown increases LINC00662, which is packaged into exosomes and activates M2 macrophage polarization, promoting osteosarcoma metastasis via CCL22.\",\n      \"method\": \"Ubiquitination assays, rescue experiments, co-immunoprecipitation implied, cell co-culture, exosome isolation assays\",\n      \"journal\": \"Clinical & experimental metastasis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — interaction with STAT3 shown with functional rescue but interaction method not fully described as reciprocal Co-IP\",\n      \"pmids\": [\"36334221\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SEDLIN interacts with PITX1 in the nucleus; SEDT-associated SEDLIN mutations (Ser73Leu, Phe83Ser, Val130Asp, Gln131Stop, but not Asp47Tyr) abolish interaction with PITX1 in yeast assays (where homodimerization masking is absent); wild-type SEDLIN localizes to both cytoplasm and nucleus.\",\n      \"method\": \"Yeast two-hybrid, COS7 cell co-expression, subcellular localization, 3D structural modeling\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — interaction confirmed in yeast null system with mutation mapping, but mammalian pulldown confounded by homodimerization\",\n      \"pmids\": [\"20498720\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PITX1 is a bicoid-related homeodomain transcription factor that functions as both a transcriptional activator and repressor: it activates hindlimb identity genes (most critically Tbx4, as well as Sox9, Six1, HoxC10/C11), POMC, LHβ and other pituitary hormone genes, p53, hTERT-suppressing circuits, and SOX9 during astrocyte differentiation, while repressing IFN-A promoters (through physical interaction with IRF3/IRF7), ERα activity, and hTERT transcription (in complex with ZCCHC10); its activity is modulated by direct protein interactions with SF-1, Pit-1, Egr-1, HIF-1β, SEDLIN, and HCV NS5A, by post-translational dephosphorylation at Y160/Y175/Y179 by PTP1B (which destabilizes PITX1), by transcriptional regulation via E2F1/TFDP1 and DUX4, and by post-transcriptional suppression through RHAU helicase and miR-19b acting on 3'UTR G-quadruplexes; in development, Pitx1 expression in the hindlimb mesenchyme is controlled by tissue-specific enhancers (PelA, PelB, Pen) whose deletion causes pelvic/hindlimb reduction, and Pitx1 haploinsufficiency causes clubfoot by disrupting a lateral lower-leg developmental field.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"PITX1 is a bicoid-related homeodomain transcription factor that functions as a master regulator of hindlimb identity, pituitary gene expression, tumor suppression, and innate immune gene modulation. In limb development, PITX1 directly activates Tbx4, HoxC10, HoxC11, Sox9, and Six1 to specify hindlimb morphology and drive chondrogenesis and myogenesis, with its tissue-restricted expression controlled by dedicated enhancers (PelA, PelB, Pen) whose deletion causes pelvic reduction and clubfoot [PMID:10049363, PMID:23201014, PMID:29273440, PMID:34903763]. In the pituitary, PITX1 activates POMC, LHβ, and other hormone gene promoters through synergistic physical interactions with Pit-1, SF-1, and Egr-1, while in cancer contexts it suppresses RAS signaling by transcriptionally activating RASAL1, directly activates p53 transcription, and represses hTERT in cooperation with ZCCHC10 [PMID:8675014, PMID:9514159, PMID:15960973, PMID:17762884, PMID:21300782]. PITX1 protein stability is regulated by PTP1B-mediated dephosphorylation at Y160/Y175/Y179 and its translation is suppressed by miR-19b and the RHAU helicase through 3′UTR-dependent mechanisms [PMID:26840794, PMID:25643913, PMID:24369427]. Dominant-negative mutations in the PITX1 homeodomain and haploinsufficiency cause autosomal dominant lower-limb malformations including clubfoot in humans and mice [PMID:18950742, PMID:21775501].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of PITX1 as a bicoid-class homeodomain factor that binds and activates the POMC promoter in pituitary cells, and physically synergizes with Pit-1, established the founding molecular activity and first partnership for this transcription factor.\",\n      \"evidence\": \"Cloning from AtT-20 cells, DNA-binding assays, reporter assays, interaction-based cloning with Pit-1\",\n      \"pmids\": [\"8675014\", \"8755540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target repertoire in pituitary unknown\", \"In vivo requirement not yet tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Demonstration that PITX1 synergizes with SF-1 on the LHβ promoter and is required upstream of Lhx3 placed PITX1 at the apex of a pituitary transcriptional cascade, resolving its pan-pituitary regulatory role.\",\n      \"evidence\": \"Antisense knockdown in αT3-1 cells, co-transfection synergy assays across multiple promoters\",\n      \"pmids\": [\"9514159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conditional pituitary-specific knockout phenotype not yet described\", \"Chromatin-level mechanism of synergy with SF-1 unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Loss-of-function in mice and gain-of-function in chick jointly established PITX1 as the hindlimb identity determinant acting through Tbx4, HoxC10, and HoxC11, answering the fundamental question of what specifies hindlimb versus forelimb.\",\n      \"evidence\": \"Pitx1 knockout mice (two independent labs), retroviral misexpression in chick wing bud, skeletal and molecular analysis\",\n      \"pmids\": [\"10101115\", \"10049363\", \"10073939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect activation of Tbx4 not resolved at chromatin level\", \"Enhancers controlling Pitx1 hindlimb-restricted expression not yet identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping the physical interaction between the PITX1 C-terminus and SF-1 N-terminus, and identifying Egr-1 as a GnRH-responsive factor that synergizes with PITX1 and SF-1, defined a tripartite transcriptional complex on the LHβ promoter linking extracellular signals to PITX1 function.\",\n      \"evidence\": \"Mammalian two-hybrid, domain-mapping mutagenesis, co-immunoprecipitation, PKC activation epistasis\",\n      \"pmids\": [\"10369682\", \"10082522\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of PITX1-SF-1 interface unknown\", \"Whether Egr-1 directly bridges PITX1 and SF-1 or acts independently on DNA not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery that PITX1 represses IFN-A promoters via the DNRE, with the C-terminal and homeodomain required, revealed a transcriptional repressor function distinct from its activator role, broadening its regulatory repertoire to innate immunity.\",\n      \"evidence\": \"Yeast one-hybrid identification, EMSA, reporter assays, antisense knockdown in virus-stimulated cells\",\n      \"pmids\": [\"11003649\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological relevance of IFN-A repression in antiviral immunity not tested in vivo\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of direct physical interaction between PITX1 homeodomain and IRF3/IRF7 clarified the mechanism of IFN-A repression as protein–protein sequestration rather than HDAC recruitment, distinguishing it mechanistically from other homeodomain repressors.\",\n      \"evidence\": \"Co-immunoprecipitation, domain-mapping mutagenesis, reporter assays, HDAC inhibitor experiments\",\n      \"pmids\": [\"12242290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide impact on interferon gene network not assessed\", \"In vivo role in viral infection not demonstrated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"An RNAi screen identified PITX1 as a suppressor of RAS signaling through transcriptional activation of RASAL1, establishing PITX1 as a tumor suppressor linking a developmental transcription factor to oncogenic pathway control.\",\n      \"evidence\": \"RNAi library screen, RAS-dependence epistasis test, soft-agar transformation, RASAL1 expression rescue in colon cancer cells\",\n      \"pmids\": [\"15960973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PITX1 loss activates RAS in non-colon cancer contexts not systematically tested\", \"Direct ChIP on RASAL1 promoter not shown in this study\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"PITX1 was shown to directly bind and activate the p53 promoter, inducing p53-dependent cell-cycle arrest and apoptosis, revealing a second major tumor-suppressive output and explaining its growth-inhibitory effects in cancer cells.\",\n      \"evidence\": \"ChIP on p53 promoter, site-directed mutagenesis, siRNA knockdown, apoptosis assays in MCF-7 cells\",\n      \"pmids\": [\"17762884\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PITX1-driven p53 activation is relevant in developmental contexts unclear\", \"Relative contribution of RASAL1 vs. p53 to tumor suppression not dissected\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"DUX4 was identified as a direct transcriptional activator of PITX1, binding a TAAT-core element in the PITX1 promoter, establishing an upstream regulatory input relevant to FSHD pathology.\",\n      \"evidence\": \"EMSA, site-directed mutagenesis, luciferase reporter, endogenous PITX1 induction by qRT-PCR in C2C12 cells\",\n      \"pmids\": [\"17984056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether DUX4-PITX1 axis operates in patient muscle in vivo not directly tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"A dominant-negative PITX1 homeodomain mutation (E130K) segregating with autosomal dominant clubfoot in a human family provided the first direct genetic link between PITX1 and human Mendelian limb malformation.\",\n      \"evidence\": \"Linkage analysis, luciferase reporter assays, dose-dependent suppression of wild-type PITX1 activity\",\n      \"pmids\": [\"18950742\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of E130K dominant-negative effect not resolved\", \"Additional PITX1 mutations in clubfoot cohorts not yet surveyed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Repeated pelvic loss in sticklebacks was mapped to regulatory deletions of the PelA pelvic enhancer of Pitx1, providing the first example of a tissue-specific enhancer deletion driving morphological evolution at a developmental transcription factor locus.\",\n      \"evidence\": \"Population genetics, enhancer deletion analysis, expression studies in sticklebacks\",\n      \"pmids\": [\"20007865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian PelA ortholog function not tested\", \"Whether PelA interacts with other enhancers in the Pitx1 locus unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple studies converged to show that PITX1 directly suppresses hTERT transcription by binding conserved sites in the hTERT promoter, that Pitx1 haploinsufficiency causes clubfoot in mice paralleling the human phenotype, and that PITX1 selectively inhibits ERα/ERβ transcriptional activity while being estrogen-inducible, broadening the gene's functional scope to telomerase regulation, quantitative limb development, and hormone receptor modulation.\",\n      \"evidence\": \"ChIP and EMSA on hTERT promoter; Pitx1+/− mouse breeding with MRI and skeletal phenotyping; ChIP-Seq on ERα binding sites with siRNA in breast cancer cells\",\n      \"pmids\": [\"21300782\", \"21775501\", \"21868451\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether hTERT suppression and ERα modulation are connected remains untested\", \"Mechanism by which PITX1 inhibits ERα but enhances PR/GR activity not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Genome-wide ChIP-Seq in mouse hindlimbs directly confirmed Tbx4, HoxC10, and HoxC11 as direct PITX1 targets and revealed preferential binding to hindlimb-specific enhancers, resolving the long-standing question of direct versus indirect Tbx4 regulation.\",\n      \"evidence\": \"ChIP-Seq with H3K27ac chromatin marking in E12.5 mouse hindlimbs\",\n      \"pmids\": [\"23201014\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Time-resolved binding dynamics during limb specification not captured\", \"Co-factor recruitment at hindlimb enhancers not identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that RHAU helicase suppresses PITX1 protein expression post-transcriptionally through the miRNA/Ago2 pathway, without affecting mRNA levels, established a non-coding RNA-based regulatory layer controlling PITX1 abundance.\",\n      \"evidence\": \"RNA co-immunoprecipitation, siRNA knockdown of RHAU/Dicer/Ago2, Western blotting\",\n      \"pmids\": [\"24369427\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific miRNA(s) recruited by RHAU to PITX1 mRNA not identified\", \"Physiological context in which RHAU-mediated suppression operates not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"PTP1B was identified as a direct phosphatase that dephosphorylates PITX1 at Y160/Y175/Y179, destabilizing the protein and reducing its transcriptional activity on RasGAP targets, linking tyrosine phosphorylation to PITX1 protein turnover and tumor suppressor output.\",\n      \"evidence\": \"FLAG pull-down, phosphorylation site mapping, PTP1B inhibition/silencing, reporter assays, xenograft validation\",\n      \"pmids\": [\"26840794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase that phosphorylates PITX1 at these tyrosines not identified\", \"Proteasomal versus other degradation pathway not determined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Integrated ChIP-Seq and RNA-Seq in Pitx1−/− hindlimbs identified ~440 direct targets including Sox9 and Six1, and showed PITX1 acts on similar chromatin states in both limbs, establishing that PITX1 redirects a generic limb program through a narrow set of hindlimb-restricted regulatory targets.\",\n      \"evidence\": \"ChIP-Seq, RNA-Seq in Pitx1−/− embryos, cross-species (mouse/Anolis) conservation analysis, H3K27ac chromatin profiling\",\n      \"pmids\": [\"29273440\", \"28807899\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single-cell resolution of target activation dynamics not achieved in these studies\", \"Pioneer factor versus cooperative binding mechanism not distinguished\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification and CRISPR-deletion of a second pelvic enhancer (PelB) downstream of Pitx1, and demonstration that H2AFY promoter deletion causes Liebenberg syndrome by unshielding the Pen enhancer from Pitx1 in forelimbs, revealed a multi-enhancer regulatory landscape with insulator-dependent limb-type specificity.\",\n      \"evidence\": \"Transgenic enhancer reporters, CRISPR deletion in mice, stickleback population genetics, whole-genome sequencing of Liebenberg syndrome patients\",\n      \"pmids\": [\"30499775\", \"30711920\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full 3D topology of enhancer–insulator interactions at Pitx1 locus not mapped at high resolution\", \"Additional enhancers contributing to hindlimb expression may exist\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"PITX1 was shown to cooperate with SOX2 and TRP63 in a feed-forward circuit maintaining squamous cell carcinoma stem cell self-renewal, with KLF4 acting as a reciprocal repressor, revealing an oncogenic role for PITX1 in specific cancer contexts distinct from its tumor-suppressive functions.\",\n      \"evidence\": \"CRISPR knockout, ChIP-Seq, RNA-Seq, functional self-renewal assays in mouse and human SCC\",\n      \"pmids\": [\"30713093\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the PITX1 tumor-suppressor and SCC self-renewal functions depend on different target gene subsets not resolved\", \"Context determinants that switch PITX1 from suppressor to oncogenic factor unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Single-cell transcriptomics of Pen enhancer-deleted embryos showed that Pitx1 regulatory landscape disruption causes heterochronic loss of high-expressing cells and clubfoot through failure to coordinate multiple enhancer activities, linking 3D chromatin architecture to quantitative Pitx1 dosage control.\",\n      \"evidence\": \"Pen enhancer CRISPR deletion, single-cell RNA-Seq, in-embryo cell tracing, 3D chromatin analysis\",\n      \"pmids\": [\"34903763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PelA, PelB, and Pen act additively or synergistically on Pitx1 dosage not quantified\", \"Upstream factors that coordinate enhancer activity remain unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the kinase(s) that phosphorylate PITX1 at tyrosine residues counteracting PTP1B; the structural basis for context-dependent switching between activator and repressor functions; whether PITX1 acts as a pioneer factor or cooperative binder at developmental enhancers; and how its tumor-suppressive versus pro-self-renewal activities are determined by cellular context.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Tyrosine kinase phosphorylating PITX1 unidentified\", \"No crystal structure of PITX1 homeodomain–DNA complex available\", \"Pioneer versus cooperative binding mechanism at limb enhancers not distinguished\", \"Molecular basis for context-dependent oncogenic vs. tumor-suppressive roles unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 10, 11, 18, 22, 26, 39]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 10, 16, 18, 22, 24, 36, 39]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 42]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0074160\", \"supporting_discovery_ids\": [0, 2, 11, 16, 18, 22, 36]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4, 5, 25, 26, 33, 34, 40]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 31]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [18, 27]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PIT1\", \"SF1\", \"EGR1\", \"IRF3\", \"IRF7\", \"ZCCHC10\", \"HIF1B\", \"SOX2\"],\n    \"other_free_text\": []\n  }\n}\n```"}